Cardlytics, Inc. (CDLX) — 8-K Filings

8-K Filings (17)

• Cardlytics Completes Asset Acquisition/Disposition on March 24, 2026 — Mar 24, 2026
  Cardlytics, Inc. filed an 8-K on March 24, 2026, announcing the completion of an acquisition or disposition of assets under Item 2.01. While the specific detail
• 8-K Filing — Dec 18, 2025
• Cardlytics Reports Director/Officer Changes — Dec 5, 2025 Risk: medium
  Cardlytics, Inc. filed an 8-K on December 5, 2025, reporting changes effective December 3, 2025. The filing pertains to the departure of directors or certain of
• Cardlytics, Inc. Files 8-K on Financials — Nov 5, 2025 Risk: low
  On November 5, 2025, Cardlytics, Inc. filed a Form 8-K to report on its results of operations and financial condition. The filing includes financial statements
• Cardlytics Files 8-K on Exit/Disposal Costs — Oct 2, 2025 Risk: medium
  On October 1, 2025, Cardlytics, Inc. filed an 8-K report to disclose cost associated with exit or disposal activities and Regulation FD disclosure. The filing d
• Cardlytics Enters Material Definitive Agreement — Jul 8, 2025 Risk: medium
  On July 7, 2025, Cardlytics, Inc. entered into a material definitive agreement. The filing does not disclose the specific details of this agreement, such as the
• Cardlytics Announces Board and Executive Changes — Jun 25, 2025 Risk: medium
  Cardlytics, Inc. announced on June 23, 2025, a series of executive and board changes. These include the departure of Director Jonathan L. Sokoloff and the appoi
• Cardlytics Director Departs; Board Changes Announced — May 20, 2025 Risk: medium
  Cardlytics, Inc. announced on May 20, 2025, the departure of Director Jonathan L. Sokoloff. The filing also covers the election of new directors and updates to
• Cardlytics Reports Termination of Material Agreement — Apr 28, 2025 Risk: medium
  Cardlytics, Inc. filed an 8-K on April 28, 2025, reporting the termination of a material definitive agreement and other events. The filing date indicates the ea
• Cardlytics CEO Transition & Board Changes — Nov 4, 2024 Risk: medium
  Cardlytics, Inc. announced on October 30, 2024, a series of executive and board changes. These include the appointment of K. Brent Turner as Chief Executive Off
• Cardlytics, Inc. Files Material Definitive Agreement — Oct 3, 2024 Risk: medium
  On September 30, 2024, Cardlytics, Inc. entered into a Material Definitive Agreement, the specifics of which are detailed in this 8-K filing. The agreement was
• Cardlytics Stockholder Meeting Results Announced — May 23, 2024 Risk: low
  On May 23, 2024, Cardlytics, Inc. filed an 8-K report to announce the results of its 2024 Annual Meeting of Stockholders. The company reported that all director
• Cardlytics CFO Departs; Interim CFO Appointed — Apr 9, 2024 Risk: medium
  Cardlytics, Inc. announced on April 9, 2024, the departure of its Chief Financial Officer, William J. Nowell, effective April 12, 2024. The company also appoint
• Cardlytics Files 8-K: Material Agreements and Financial Obligations — Apr 1, 2024 Risk: medium
  On April 1, 2024, Cardlytics, Inc. entered into a material definitive agreement related to a direct financial obligation. The company also reported on the creat
• Cardlytics Files 8-K for Material Definitive Agreement — Mar 18, 2024 Risk: medium
  On March 18, 2024, Cardlytics, Inc. filed an 8-K report to disclose its entry into a material definitive agreement. The filing also includes financial statement
• Cardlytics Files 8-K on Material Agreement & Financials — Jan 29, 2024
  Cardlytics, Inc. filed an 8-K on January 29, 2024, reporting an "Entry into a Material Definitive Agreement" and "Results of Operations and Financial Condition"
• Cardlytics 8-K: Officer/Director Changes, Comp Arrangements — Jan 2, 2024
  Cardlytics, Inc. filed an 8-K on January 2, 2024, reporting an event that occurred on December 29, 2023. This filing indicates a change related to 'Departure of

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX